Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
10/03/2021

Archive: 10/03/2021

Clinical trial shows alcohol use disorder recovery can start without sobriety

Harm reduction treatment helped people experiencing homelessness and alcohol use disorder reduce their drinking and improve their health-even if they didn't quit drinking alcohol.

Mar 10, 2021

0

22

Sugar purchased in soft drinks fell 10% following introduction of industry levy

The amount of sugar purchased by households through soft drinks fell by 10% in the year following the introduction of the UK Soft Drinks Industry Levy, say researchers at the University of Cambridge.

Mar 10, 2021

0

22

Trial compares two gestational diabetes screening methods

There were no significant differences in health outcomes for pregnant women who were diagnosed with gestational diabetes or their babies using two different clinically recommended screening methods, according to results from ...

Mar 10, 2021

0

7

Promising role for whole genome sequencing in guiding blood cancer treatment

For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. ...

Mar 10, 2021

0

12

Second shot of COVID-19 vaccine may not be necessary in previously infected individuals: study

A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who have previously been infected by the virus, thus eliminating the need for a second dose and helping ...

Mar 10, 2021

0

297

AstraZeneca vaccine not to blame for Austria death: EMA

Europe's medicines watchdog said Wednesday a preliminary probe showed that a batch of AstraZeneca vaccines used in Austria was likely not to blame for the death of a nurse who received a jab.

Mar 10, 2021

0

7

Medicare paid 50% more for neurology drugs over 5 years while claims rose only 8%

A new study of Medicare payments has found that over a five-year period, the payments for medications prescribed to people with neurologic conditions like multiple sclerosis (MS), Parkinson's disease and epilepsy increased ...

Mar 10, 2021

0

5

Diet high in healthful plant-based food may reduce risk of stroke by 10%

Eating a healthy, plant-based diet that includes foods like vegetables, whole grains and beans, and decreasing intakes of less healthy foods like refined grains or added sugars may reduce your risk of having a stroke by up ...

Mar 10, 2021

0

52

Drugmaker Lilly says Covid treatment slashed hospitalization and deaths

US drugmaker Eli Lilly's combination of two synthetic antibodies reduced hospitalizations and deaths in high-risk patients recently diagnosed with COVID-19 by 87 percent in trials, the company said Wednesday.

Mar 10, 2021

0

6

Study finds lower dose of ketamine equally effective in reducing pain

A recent Loyola Medicine study found that reducing the standard dose of IV-administered ketamine in half is as effective as the larger, standard dose in reducing pain in adults.

Mar 10, 2021

0

30

page 1 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us